Stay informed with the latest litigation news. Explore now

GlaxoSmithKline LLC v. Sun Pharmaceutical Industries Ltd. - 1:25-cv-01170

Explore the details of the GlaxoSmithKline LLC v. Sun Pharmaceutical Industries Ltd. case under case number 1:25-cv-01170 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-01170
Filing Date
Sep 18, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Sun Pharmaceutical Industries Ltd. -
Merck Sharp & Dohme LLC -
TESARO, Inc. -
GlaxoSmithKline LLC -

Patents Involved

This case involves 3 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11091459B2
-US11673877B2
-US8071623B2

Docket Entries